Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, expectations were $0.92. Operator: Good day, ladies and gentlemen, and ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Analysts have noted that Illumina is placing increased emphasis on the "total cost of sequencing" as a competitive advantage. This approach aims to streamline the entire workflow, potentially ...

BOSTON - Volta Labs, a genomics applications company, has integrated its Callisto™ Sample Prep System into Ginkgo Bioworks' Illumina (NASDAQ:ILMN) sequencing workflow, aiming to streamline and ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and ...

We recently published a list of Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Illumina, Inc.

We also believe that Illumina is more than a sequencing company. It’s an entire workflow and ecosystem, from sample prep to sequencing and bioinformatic analytics. While it used to be that the ...

The Clinical Workflow Solutions Market has been witnessing significant growth in recent years, driven by increasing demand for improved efficiency and better patient outcomes in healthcare facilities.